StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.90+0.05 (+5.86%)

Close on Nov 20, 2026Market cap $7.26MP/E –Yield –

Immuron operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2026 it was -A$3.85M. The highest annual figure on record is -A$2.87M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$3.85M–
FY2025Jun 30, 2025-A$5.34M–
FY2024Jun 30, 2024-A$5.80M–
FY2023Jun 30, 2023-A$3.57M–
FY2022Jun 30, 2022-A$2.87M–
FY2021Jun 30, 2021-A$8.38M–
FY2020Jun 30, 2020-A$2.91M–
FY2019Jun 30, 2019-A$4.66M–
FY2018Jun 30, 2018-A$3.05M–
FY2017Jun 30, 2017-A$6.72M–

More Immuron figures

See a number that looks wrong?